GMED vs. TFX, IART, PODD, ATEC, BAX, RMD, INSP, PEN, MMSI, and HAE
Should you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include Teleflex (TFX), Integra LifeSciences (IART), Insulet (PODD), Alphatec (ATEC), Baxter International (BAX), ResMed (RMD), Inspire Medical Systems (INSP), Penumbra (PEN), Merit Medical Systems (MMSI), and Haemonetics (HAE). These companies are all part of the "surgical & medical instruments" industry.
Teleflex (NYSE:TFX) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.
In the previous week, Teleflex had 4 more articles in the media than Globus Medical. MarketBeat recorded 6 mentions for Teleflex and 2 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.11 beat Teleflex's score of 0.91 indicating that Teleflex is being referred to more favorably in the media.
Globus Medical received 24 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 67.83% of users gave Globus Medical an outperform vote while only 59.68% of users gave Teleflex an outperform vote.
Teleflex has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500.
Teleflex has a net margin of 11.98% compared to Teleflex's net margin of 7.83%. Globus Medical's return on equity of 14.98% beat Teleflex's return on equity.
Teleflex presently has a consensus target price of $267.50, indicating a potential upside of 29.49%. Globus Medical has a consensus target price of $66.33, indicating a potential upside of 31.74%. Given Teleflex's higher probable upside, analysts clearly believe Globus Medical is more favorable than Teleflex.
Teleflex has higher revenue and earnings than Globus Medical. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
95.6% of Teleflex shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 1.4% of Teleflex shares are held by company insiders. Comparatively, 24.3% of Globus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Teleflex beats Globus Medical on 10 of the 16 factors compared between the two stocks.
Get Globus Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Globus Medical Competitors List
Related Companies and Tools
